GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+8.91%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$241M
AUM Growth
+$241M
(+41%)
Cap. Flow
+$58.3M
Cap. Flow
% of AUM
24.24%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
90
New
33
Increased
13
Reduced
9
Closed
27
Top Buys
| 1 |
Community Health Systems
CYH
|
$7.84M |
| 2 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$6.94M |
| 3 |
CELG
Celgene Corp
CELG
|
$6.92M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$6.03M |
| 5 |
Merck
MRK
|
$5.75M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$6.13M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$5.28M |
| 3 |
Assertio
ASRT
|
$4.83M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$4.45M |
| 5 |
ADXS
Advaxis, Inc.
ADXS
|
$4.3M |
Sector Composition
| 1 | Healthcare | 82.76% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zimmer Biomet
ZBH
$21B
| $11.8M | 4.23% | 100,000 +13,800 | +16% | +$1.62M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $10.4M | 3.75% | 35,000 +17,500 | +100% | +$5.21M |
|
|
3
Community Health Systems
CYH
$387M
| $7.84M | 2.82% | +150,000 | New | +$7.84M |
|
|
NUVA
4
DELISTED
NuVasive, Inc.
NUVA
| $7.36M | 2.65% | 160,000 +70,000 | +78% | +$3.22M |
|
5
Puma Biotechnology
PBYI
$254M
| $7.08M | 2.55% | 30,000 | – | – |
|
|
ZSPH
6
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $6.94M | 2.5% | +165,000 | New | +$6.94M |
|
|
ZLTQ
7
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $6.94M | 2.49% | 225,000 +65,000 | +41% | +$2M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $6.92M | 2.49% | +60,000 | New | +$6.92M |
|
|
PTLA
9
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $6.83M | 2.46% | 180,000 +30,000 | +20% | +$1.14M |
|
|
SAGE
10
DELISTED
Sage Therapeutics
SAGE
| $6.03M | 2.17% | +120,000 | New | +$6.03M |
|
|
DYAX
11
DELISTED
DYAX CORPORATION
DYAX
| $5.86M | 2.11% | 350,000 +25,000 | +8% | +$419K |
|
12
Merit Medical Systems
MMSI
$5.36B
| $5.78M | 2.08% | 300,000 +225,000 | +300% | +$4.33M |
|
|
13
Merck
MRK
$210B
| $5.75M | 2.07% | +100,000 | New | +$5.75M |
|
|
WMGI
14
DELISTED
Wright Medical Group Inc
WMGI
| $5.16M | 1.86% | 200,000 -35,000 | -15% | -$903K |
|
15
Becton Dickinson
BDX
$55.3B
| $5.03M | 1.81% | +35,000 | New | +$5.03M |
|
|
GNCA
16
DELISTED
Genocea Biosciences, Inc.
GNCA
| $4.98M | 1.79% | +420,000 | New | +$4.98M |
|
17
Arcturus Therapeutics
ARCT
$462M
| $4.5M | 1.62% | +800,000 | New | +$4.5M |
|
18
Adverum Biotechnologies
ADVM
$64.6M
| $4.46M | 1.6% | 110,000 -15,000 | -12% | -$608K |
|
19
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.36M | 1.57% | 35,000 -5,000 | -13% | -$623K |
|
|
VIRX
20
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $4.29M | 1.54% | +1,750,000 | New | +$4.29M |
|
|
CPHD
21
DELISTED
Cepheid Inc
CPHD
| $4.27M | 1.53% | 75,000 -25,000 | -25% | -$1.42M |
|
22
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.18M | 1.5% | 40,000 -15,000 | -27% | -$1.57M |
|
|
RVNC
23
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.15M | 1.49% | +200,000 | New | +$4.15M |
|
|
GWPH
24
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.1M | 1.47% | +45,000 | New | +$4.1M |
|
25
AbbVie
ABBV
$372B
| $4.1M | 1.47% | +70,000 | New | +$4.1M |
|